Giulia Malaguarnera
Giulia Malaguarnera
Bestätigte E-Mail-Adresse bei
Zitiert von
Zitiert von
Bifidobacterium longum with fructo-oligosaccharides in patients with non alcoholic steatohepatitis
M Malaguarnera, M Vacante, T Antic, M Giordano, G Chisari, R Acquaviva, ...
Digestive diseases and sciences 57 (2), 545-553, 2012
Hepatic echinococcosis: clinical and therapeutic aspects
G Nunnari, MR Pinzone, S Gruttadauria, BM Celesia, G Madeddu, ...
World journal of gastroenterology: WJG 18 (13), 1448, 2012
Serum markers of hepatocellular carcinoma
G Malaguarnera, M Giordano, I Paladina, M Berretta, A Cappellani, ...
Digestive diseases and sciences 55 (10), 2744-2755, 2010
Potential role of probiotics on colorectal cancer prevention
M Uccello, G Malaguarnera, F Basile, V D’agata, M Malaguarnera, ...
BMC surgery 12 (1), 1-8, 2012
Hepatocellualar carcinoma serum markers
G Bertino, A Ardiri, M Malaguarnera, G Malaguarnera, N Bertino, ...
Seminars in oncology 39 (4), 410-433, 2012
What is changing in indications and treatment of hepatic hemangiomas. A review
A Toro, AE Mahfouz, A Ardiri, M Malaguarnera, G Malaguarnera, F Loria, ...
Annals of hepatology 13 (4), 327-339, 2014
Toxic hepatitis in occupational exposure to solvents
G Malaguarnera, E Cataudella, M Giordano, G Nunnari, G Chisari, ...
World journal of gastroenterology: WJG 18 (22), 2756, 2012
Neurotoxicity of acrylamide in exposed workers
M Pennisi, G Malaguarnera, V Puglisi, L Vinciguerra, M Vacante, ...
International journal of environmental research and public health 10 (9 …, 2013
Immuno-modulatory effects of vitamin D3 in human monocyte and macrophages
M Di Rosa, G Malaguarnera, C De Gregorio, M Palumbo, G Nunnari, ...
Cellular immunology 280 (1), 36-43, 2012
Bifidobacterium combined with fructo-oligosaccharide versus lactulose in the treatment of patients with hepatic encephalopathy
M Malaguarnera, MP Gargante, G Malaguarnera, M Salmeri, S Mastrojeni, ...
European journal of gastroenterology & hepatology 22 (2), 199-206, 2010
Gut microbiota in alcoholic liver disease: pathogenetic role and therapeutic perspectives
G Malaguarnera, M Giordano, G Nunnari, G Bertino, M Malaguarnera
World Journal of Gastroenterology: WJG 20 (44), 16639, 2014
Lipoprotein (a) in cardiovascular diseases
M Malaguarnera, M Vacante, C Russo, G Malaguarnera, T Antic, ...
BioMed research international 2013, 2013
Acetyl-l-carnitine reduces depression and improves quality of life in patients with minimal hepatic encephalopathy
M Malaguarnera, R Bella, M Vacante, M Giordano, G Malaguarnera, ...
Scandinavian journal of gastroenterology 46 (6), 750-759, 2011
Serum markers of intrahepatic cholangiocarcinoma
G Malaguarnera, I Paladina, M Giordano, M Malaguarnera, G Bertino, ...
Disease markers 34 (4), 219-228, 2013
Gut flora and hepatic encephalopathy in patients with cirrhosis
SM Riordan, R Williams, SM Riordan, R Williams, BC Sharma, P Sharma, ...
New England Journal of Medicine 362 (12), 1140, 2010
Chronic hepatitis C: This and the new era of treatment
G Bertino, A Ardiri, M Proiti, G Rigano, E Frazzetto, S Demma, MI Ruggeri, ...
World journal of hepatology 8 (2), 92, 2016
Hepatocellular carcinoma: novel molecular targets in carcinogenesis for future therapies
G Bertino, S Demma, A Ardiri, M Proiti, G Malaguarnera, N Bertino, ...
BioMed research international 2014, 2014
Evaluation of CHI3L-1 and CHIT-1 expression in differentiated and polarized macrophages
M Di Rosa, G Malaguarnera, C De Gregorio, F Drago, L Malaguarnera
Inflammation 36 (2), 482-492, 2013
The retina as an early biomarker of neurodegeneration in a rotenone-induced model of Parkinson’s disease: evidence for a neuroprotective effect of rosiglitazone in the eye and …
EM Normando, BM Davis, L De Groef, S Nizari, LA Turner, N Ravindran, ...
Acta neuropathologica communications 4 (1), 1-15, 2016
Probiotics in the gastrointestinal diseases of the elderly
G Malaguarnera, F Leggio, M Vacante, M Motta, M Giordano, A Biondi, ...
The journal of nutrition, health & aging 16 (4), 402-410, 2012
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20